FDA Recalls Testosterone Micronized Bulk Due to cGMP Deviations
Qinhuangdao Zizhu Pharmaceutical is recalling Testosterone Micronized Bulk due to cGMP deviations and lack of quality assurance. The product was distributed to six states.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classifies this recall as Class II. Per the rubric, an FDA Class II recall is assigned a severity score of 4 (Severe), particularly when structural or quality assurance failures like cGMP deviations are involved.
Plain-English summary
The U.S. Food and Drug Administration (FDA) has issued a recall for Testosterone Micronized, Bulk, manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd. The recall is due to Current Good Manufacturing Practice (cGMP) deviations and a lack of quality assurance. The product is intended for prescription compounding and is available by prescription only.
The affected product is identified by NDC 44132-006-06. The recall covers batches 78801507001 through 78901612003, with expiration dates ranging from June 22, 2017, to November 21, 2018. The product was distributed to New York, Texas, South Carolina, Colorado, Minnesota, and New Jersey.
Consumers and healthcare providers should stop using the recalled product and contact their pharmacist or healthcare provider for guidance on replacement or disposal. The FDA classifies this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Testosterone Micronized, Bulk, Rx only, For Prescription Compounding, Manufactured by Qinhuangdao Zizhu Pharmaceutical Co., Ltd., Qinhuangdao 066004, China (NDC 44132-006-06)
- Manufacturer
- Qinhuangdao Zizhu Pharmaceutical, Co.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch 78801507001 to 78901612003
- exp 6/22/2017 through 11/21/2018
Distribution
Part of a larger recall action
This product is one of 7 recalled by Qinhuangdao Zizhu Pharmaceutical, Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Qinhuangdao Zizhu Pharmaceutical, Co.
See all →- ModerateFDA Recalls Levonorgestrel Bulk Drug Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- SevereFDA Recalls Ethinyl Estradiol Bulk Drug Due to Quality Assurance Failures
FDA (Drugs) · 2017-04-19
- SevereFDA Recalls Estrone Micronized Bulk Drug Due to Quality Assurance Failures
FDA (Drugs) · 2017-04-19
- ModerateFDA Recalls Estradiol Micronized Bulk Due to cGMP Deviations
FDA (Drugs) · 2017-04-19
- ModerateFDA Recalls Estriol Micronized Bulk Drug Due to Quality Assurance Failures
FDA (Drugs) · 2017-04-19
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14